Placebo matching with BMS-823778

DRUG3 trials

Sponsors

Bristol-Myers Squibb

Conditions

Atherosclerotic Cardiovascular DiseaseHypertensionType 2 Diabetes Mellitus

Phase 1

Japanese Phase 1 Multiple Ascending Dose Study

CompletedNCT01515202

Bristol-Myers SquibbType 2 Diabetes Mellitus

Start: 2012-03-31End: 2012-09-30Updated: 2012-12-05

Phase 2

Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients

TerminatedNCT01602367

Bristol-Myers SquibbHypertension

Start: 2012-07-31End: 2012-11-30Updated: 2015-10-12

Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis

WithdrawnNCT01666704

Bristol-Myers SquibbAtherosclerotic Cardiovascular Disease

Start: 2014-04-30End: 2016-05-31Updated: 2013-06-21